Search Results
Apr 10, 2026, 19:06 ET Khoros Launches Iris® AI: Your Messenger Across Every Brand Channel
fully transformed into an AI-DNA company, we were able to rewrite over 15 years of legacy technical debt across multiple products into one cohesive, AI-generated codebase in less
More news about: Khoros, LLC
Apr 10, 2026, 18:55 ET Khoros Launches Aurora AI: A New Dawn for Enterprise Community
fully transformed into an AI-DNA company, we didn't bolt AI onto legacy software," said Eric Vaughan, CEO of IgniteTech and Khoros. "We rebuilt Khoros' products from the inside out.
More news about: Khoros, LLC
Apr 10, 2026, 18:43 ET Khoros Launches Iris® AI: Your Messenger Across Every Brand Channel
fully transformed into an AI-DNA company, we were able to rewrite over 15 years of legacy technical debt across multiple products into one cohesive, AI-generated codebase in less
More news about: Khoros, LLC
Apr 10, 2026, 18:35 ET Khoros Launches Aurora AI: A New Dawn for Enterprise Community
fully transformed into an AI-DNA company, we didn't bolt AI onto legacy software," said Eric Vaughan, CEO of IgniteTech and Khoros. "We rebuilt Khoros' products from the inside out.
More news about: Khoros, LLC
Apr 10, 2026, 09:46 ET Pendulum Therapeutics Expands Clinical Collaboration to Advance Microbiome Research in Women's Health and Dermatology
will utilize Pendulum's portfolio of microbiome-targeted products and leverage the company's expertise in strain isolation, anaerobic manufacturing, DNA sequencing, and clinical validation.Colleen Cutcliffe, PhD, Co-founder and CEO of Pendulum Therapeutics, said the collaboration reflects
More news about: Pendulum Therapeutics
Apr 10, 2026, 03:45 ET North America Leads Vanilla Bean Market with 37.8% Share as Global Industry Set to Reach USD 2.3 Billion by 2031, Says Mordor Intelligence
Ethical Sourcing Traceability is emerging as a defining factor in the vanilla bean market share, with manufacturers investing in blockchain and DNA-based verification systems.These technologies improve supply chain transparency, reduce theft, and ensure compliance with evolving regulatory
More news about: Mordor Intelligence Private Limited
Apr 09, 2026, 16:30 ET Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Apr 09, 2026, 11:00 ET Dyson introduces the HushJet™ Mini Cool fan: 17 years of airflow mastery, now in the palm of your hand
(1.5in) is a special measurement. It's the representation of how we make things smaller, lighter, and better performing – it is in Dyson's engineering DNA. It's similar to the diameter of a watch face but also the diameter shared by the Dyson Supersonic rTM hair dryer, the Dyson PencilVac
More news about: Dyson
Apr 09, 2026, 10:30 ET MUGLER FRAGRANCES IS THE OFFICIAL SPONSOR OF CARDI B'S LITTLE MISS DRAMA TOUR
platforms. "Cardi B is a fearless force of nature who embodies confidence, individuality, and creative freedom values that are deeply rooted in Mugler's DNA," said Lynn Yu, Chief Executive Officer of Mugler Fragrances US. "Becoming the official sponsor of the Little Miss Drama Tour has allowed us to
More news about: Mugler
Apr 09, 2026, 10:00 ET Yellowfin Expands Its Lineup with the New 48 Offshore
/PRNewswire/ -- Yellowfin today announced the 48 Offshore, the latest addition to its lineup that celebrates both performance and utility. Blending the DNA of the brand's 42 and 54 Offshore models, the 48 Offshore offers a seaworthy, high-performance fishing platform in a class of its own. Key innovations
More news about: Warbird Marine Holdings
Apr 09, 2026, 09:00 ET Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Apr 09, 2026, 08:55 ET Precision Nanomedicine to Target the Most Challenging Tumors
advance the next generation of targeted cancer treatments through the development of Janus base nanomaterials (JBNs). JBNs are engineered from synthetic DNA-inspired molecules that self‑assemble into nanotubes that can be loaded with a therapeutic.
More news about: International Space Station National Lab
Apr 09, 2026, 08:15 ET Mimulus and GenScript Partner to Scale the World's First Zero-Watt Molecular Archive Infrastructure for the AI Era
Technology™, and GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, today announced a multi-year, milestone-based strategic collaboration to industrialize DNA-based data storage. As global cold archive data volumes race toward 200 zettabytes by
More news about: Mimulus Corp
Apr 09, 2026, 08:01 ET Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
EsoGuard® Esophageal DNA Test, performed on samples collected in a brief, noninvasive office procedure with its
More news about: Lucid Diagnostics
Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology™, today announced a strategic collaboration to industrialize DNA-based data storage, a technology poised to transform how the world preserves
More news about: GenScript Biotech Corporation
Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in Molecular Archive Technology™, today announced a strategic collaboration to industrialize DNA-based data storage, a technology poised to transform how the world preserves
More news about: GenScript Biotech Corporation
Apr 09, 2026, 07:30 ET Galmed Announces the Breakthrough Development of a Brain Penetrating New Formulation of its SCD1 inhibitor, Aramchol
2026."Ronen Eavri, Co-founder & CEO of Barcode Nanotech, commented: "Barcode Nanotech has developed a library of novel lipids for RNA and DNA, LNP-based delivery, through a unique in vivo & AI-based screening platform which allow simultaneously screening of hundreds of different nanoparticle
More news about: Galmed Pharmaceuticals Ltd.
Apr 09, 2026, 03:53 ET Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts for 33.21% Share, with Asia-Pacific as the Fastest-Growing Region, Says Mordor Intelligence
DNA Methylation Market Share - The DNA methylation market stood at USD 2.95 billion in 2025 and is expected to reach USD 3.74 billion by 2030, growing at a CAGR of 4.8%
More news about: Mordor Intelligence Private Limited
Apr 08, 2026, 10:00 ET GCAR and Purdue Pharma L.P. Announce Initiation of Tinostamustine in GBM AGILE Trial
two potentially synergistic mechanisms of action: bifunctional DNA alkylating activity, which triggers apoptosis, and pan histone deacetylase inhibition (or HDAC inhibition), which in addition to improving alkylating agent access to DNA, has been shown to disrupt oncogenic signaling pathways and enhance
More news about: Global Coalition for Adaptive Research
Apr 08, 2026, 08:00 ET Stealth BioTherapeutics Appoints David A. Brown, Ph.D., as Chief Scientific Officer to Advance the Company's Pioneering Work in Mitochondrial Medicine
is studying elamipretide in additional indications, including dry age-related macular degeneration and primary mitochondrial disease due to nuclear DNA mutations, including in polymerase gamma, and is developing its next-in-class clinical-stage candidate, bevemipretide, for ophthalmic and neurological
More news about: Stealth BioTherapeutics Inc.
Apr 08, 2026, 04:00 ET Ribbon Bio Appoints Dr. Urs Spitz as Chair of the Board
Bio Ribbon Bio is a cell-free DNA developer transforming access to high-fidelity DNA molecules. By producing DNA independent of bacterial-mediated processes, Ribbon sidesteps many of the limitations inherent to traditional plasmid-based approaches, delivering purer DNA, faster production timelines, and
More news about: Ribbon Bio
Apr 07, 2026, 20:21 ET REJURAN Cosmetics Debuts at Sephora U.S. with Sold-Out LA Pop-Up
Korea's original PDRN-based skincare brand, REJURAN® Cosmetics is powered by patented c-PDRN® derived from sustainably sourced salmon DNA and PharmaResearch's proprietary DNA Optimizing Technology (DOT®). The formulations are designed to help improve skin texture, hydration and radiance while supporting
More news about: REJURAN Cosmetics
Apr 07, 2026, 15:16 ET Rosalind Franklin University Incubator Company Presents Promising Glioblastoma Therapy Data at Major Brain Cancer Conference
embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA. Recognized for its research in areas including neuroscience, brain-related diseases, inherited disorders, diabetes, obesity, and gait and balance, RFU
More news about: Rosalind Franklin University of Medicine and Science
Apr 07, 2026, 09:00 ET Method Communications Names Lexy King SVP to Lead New Corporate Communications Specialist Group
tissue linking a company's financial narrative and public affairs to its internal culture. I joined Method because our challenger mindset, creative DNA, and deep tech expertise allow us to tackle these shifting issues head-on and turn complex pressures into a clear path forward for clients."The
More news about: Method Communications
Apr 07, 2026, 08:15 ET Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Maravai, he served in senior leadership roles at Danaher Corporation, including Senior Vice President, Genomic Medicines, and President of Integrated DNA Technologies (IDT). Mr. Martin joined Danaher following their 2018 acquisition of IDT, after helping to lead the sale process. Prior to acquisition,
More news about: Azenta